TALPHERA, INC. Selling, General and Administrative Expense
TALPHERA, INC. (TLPH) reported Selling, General and Administrative Expense of $2.23 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-12
- TALPHERA, INC. selling, general and administrative expense for the quarter ending 2026-06-30 was $2.23M, a 1.87% increase year-over-year.
- TALPHERA, INC. selling, general and administrative expense for the quarter ending 2026-03-31 was $2.30M, a 29.54% increase year-over-year.
- TALPHERA, INC. selling, general and administrative expense for the quarter ending 2025-12-31 was $1.89M, a 13.09% increase year-over-year.
- TALPHERA, INC. selling, general and administrative expense for the quarter ending 2025-09-30 was $1.62M, a 4.48% decline year-over-year.
- TALPHERA, INC. selling, general and administrative expense for fiscal 2025 was $7.48M, a 12.36% decline from fiscal 2024.
- TALPHERA, INC. selling, general and administrative expense for fiscal 2024 was $8.53M, a 28.85% decline from fiscal 2023.
- TALPHERA, INC. selling, general and administrative expense for fiscal 2023 was $11.99M, a 29.49% decline from fiscal 2022.
- TALPHERA, INC. selling, general and administrative expense for fiscal 2022 was $17.01M.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 3 month as first filed | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 6 month as first filed | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 9 month as first filed | Selling, General and Administrative Expense 12 month | Selling, General and Administrative Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.23M 10-Q · filed 2026-08-12 | $4.53M 10-Q · filed 2026-08-12 | $6.42M derived: sum of 3 quarters · filed 2026-08-12 | $8.04M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2026-03-31 | $2.30M 10-Q · filed 2026-05-13 | $4.19M derived: sum of 2 quarters · filed 2026-05-13 | $5.81M derived: sum of 3 quarters · filed 2026-05-13 | $8.00M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-12-31 | $1.89M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $3.51M derived: sum of 2 quarters · filed 2026-03-23 | $5.71M derived: sum of 3 quarters · filed 2026-08-12 | $7.48M 10-K · filed 2026-03-23 | ||||
| 2025-09-30 | $1.62M 10-Q · filed 2025-11-12 | $3.81M derived: sum of 2 quarters · filed 2026-08-12 | $5.59M 10-Q · filed 2025-11-12 | $7.26M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-06-30 | $2.19M 10-Q · filed 2026-08-12 | $3.97M 10-Q · filed 2026-08-12 | $5.64M derived: sum of 3 quarters · filed 2026-08-12 | $7.34M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-03-31 | $1.77M 10-Q · filed 2026-05-13 | $3.45M derived: sum of 2 quarters · filed 2026-05-13 | $5.14M derived: sum of 3 quarters · filed 2026-05-13 | $7.50M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | $1.67M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $3.37M derived: sum of 2 quarters · filed 2026-03-23 | $5.73M derived: sum of 3 quarters · filed 2026-03-23 | $8.53M 10-K · filed 2026-03-23 | ||||
| 2024-09-30 | $1.70M 10-Q · filed 2025-11-12 | $4.06M derived: sum of 2 quarters · filed 2025-11-12 | $6.86M 10-Q · filed 2025-11-12 | $9.66M derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | $2.36M 10-Q · filed 2025-08-14 | $5.17M 10-Q · filed 2025-08-14 | $7.96M derived: sum of 3 quarters · filed 2025-08-14 | $10.21M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | $2.80M 10-Q · filed 2025-05-14 | $5.60M derived: sum of 2 quarters · filed 2025-05-14 | $7.85M derived: sum of 3 quarters · filed 2025-05-14 | $10.52M derived: sum of 4 quarters · filed 2025-05-14 | ||||
| 2023-12-31 | $2.79M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $5.04M derived: sum of 2 quarters · filed 2025-03-31 | $7.71M derived: sum of 3 quarters · filed 2025-03-31 | $11.99M 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | $2.25M 10-Q · filed 2024-11-13 | $4.92M derived: sum of 2 quarters · filed 2024-11-13 | $9.20M 10-Q · filed 2024-11-13 | $14.43M derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | $2.67M 10-Q · filed 2024-08-14 | $6.95M 10-Q · filed 2024-08-14 | $12.18M derived: sum of 3 quarters · filed 2024-08-14 | $15.90M derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | $4.28M 10-Q · filed 2024-05-14 | $9.51M derived: sum of 2 quarters · filed 2024-05-14 | $13.23M derived: sum of 3 quarters · filed 2024-05-14 | $17.19M derived: sum of 4 quarters · filed 2024-05-14 | ||||
| 2022-12-31 | $5.23M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | $8.95M derived: sum of 2 quarters · filed 2024-03-06 | $12.91M derived: sum of 3 quarters · filed 2024-03-06 | $17.01M 10-K · filed 2024-03-06 | $25.67M 10-K · filed 2023-03-31 | |||
| 2022-09-30 | $3.72M 10-Q · filed 2023-11-14 | $5.26M 10-Q · filed 2022-11-14 | $7.68M derived: sum of 2 quarters · filed 2023-11-14 | $11.78M 10-Q · filed 2023-11-14 | $19.42M 10-Q · filed 2022-11-14 | $2.29M derived: sum of 4 quarters · filed 2023-11-14 | ||
| 2022-06-30 | $3.96M 10-Q · filed 2023-08-10 | $6.82M 10-Q · filed 2022-08-11 | $8.06M 10-Q · filed 2023-08-10 | $14.16M 10-Q · filed 2022-08-11 | -$1.43M derived: sum of 3 quarters · filed 2023-08-10 | $7.21M derived: sum of 4 quarters · filed 2023-08-10 | ||
| 2022-03-31 | $4.10M 10-Q · filed 2023-05-10 | $7.34M 10-Q · filed 2022-05-16 | -$5.39M derived: sum of 2 quarters · filed 2023-08-01 | $3.25M derived: sum of 3 quarters · filed 2023-08-01 | $11.94M derived: sum of 4 quarters · filed 2023-08-01 | |||
| 2021-12-31 | -$9.49M derived: 8-K 12 month − 10-Q 9 month · filed 2023-08-01 | -$850.00K derived: sum of 2 quarters · filed 2023-08-01 | $7.84M derived: sum of 3 quarters · filed 2023-08-01 | $15.49M 8-K · filed 2023-08-01 | $30.93M 10-K · filed 2022-03-10 | |||
| 2021-09-30 | $8.64M 10-Q · filed 2022-11-14 | $17.33M derived: sum of 2 quarters · filed 2022-11-14 | $24.98M 10-Q · filed 2022-11-14 | $32.82M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $8.69M 10-Q · filed 2022-08-11 | $16.34M 10-Q · filed 2022-08-11 | $24.18M derived: sum of 3 quarters · filed 2022-08-11 | $31.78M derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | $7.64M 10-Q · filed 2022-05-16 | $15.49M derived: sum of 2 quarters · filed 2022-05-16 | $23.09M derived: sum of 3 quarters · filed 2022-05-16 | $30.66M derived: sum of 4 quarters · filed 2022-05-16 | ||||
| 2020-12-31 | $7.85M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $15.44M derived: sum of 2 quarters · filed 2022-03-10 | $23.02M derived: sum of 3 quarters · filed 2022-03-10 | $36.33M 10-K · filed 2022-03-10 | ||||
| 2020-09-30 | $7.60M 10-Q · filed 2021-11-15 | $15.17M derived: sum of 2 quarters · filed 2021-11-15 | $28.48M 10-Q · filed 2021-11-15 | $41.27M derived: sum of 4 quarters · filed 2021-11-15 | ||||
| 2020-06-30 | $7.58M 10-Q · filed 2021-08-16 | $20.89M 10-Q · filed 2021-08-16 | $33.67M derived: sum of 3 quarters · filed 2021-08-16 | $44.61M derived: sum of 4 quarters · filed 2021-08-16 | ||||
| 2020-03-31 | $13.31M 10-Q · filed 2021-05-17 | $26.10M derived: sum of 2 quarters · filed 2021-05-17 | $37.03M derived: sum of 3 quarters · filed 2021-05-17 | $48.36M derived: sum of 4 quarters · filed 2021-05-17 | ||||
| 2019-12-31 | $12.79M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $23.72M derived: sum of 2 quarters · filed 2021-03-15 | $35.05M derived: sum of 3 quarters · filed 2021-03-15 | $45.03M 10-K · filed 2021-03-15 | ||||
| 2019-09-30 | $10.94M 10-Q · filed 2020-11-05 | $22.27M derived: sum of 2 quarters · filed 2020-11-05 | $32.24M 10-Q · filed 2020-11-05 | $39.89M derived: sum of 4 quarters · filed 2021-03-15 | ||||
| 2019-06-30 | $11.33M 10-Q · filed 2020-08-10 | $21.30M 10-Q · filed 2020-08-10 | $28.95M derived: sum of 3 quarters · filed 2021-03-15 | $34.14M derived: sum of 4 quarters · filed 2021-03-15 | ||||
| 2019-03-31 | $9.98M 10-Q · filed 2020-05-11 | $17.62M derived: sum of 2 quarters · filed 2021-03-15 | $22.81M derived: sum of 3 quarters · filed 2021-03-15 | $26.76M derived: sum of 4 quarters · filed 2021-03-15 | ||||
| 2018-12-31 | $7.65M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $12.84M derived: sum of 2 quarters · filed 2021-03-15 | $16.78M derived: sum of 3 quarters · filed 2021-03-15 | $20.77M 10-K · filed 2021-03-15 | ||||
| 2018-09-30 | $5.19M 10-Q · filed 2019-11-07 | $9.13M derived: sum of 2 quarters · filed 2019-11-07 | $13.12M 10-Q · filed 2019-11-07 | |||||
| 2018-06-30 | $3.94M 10-Q · filed 2019-08-06 | $7.93M 10-Q · filed 2019-08-06 | ||||||
| 2018-03-31 | $3.98M 10-Q · filed 2019-05-09 | |||||||
| 2017-12-31 | $16.61M 10-K · filed 2020-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |